Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-03

Clinical Trial Update: Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME) [Phase 2]

View source ↗

Summary

This update covers a Phase 2 trial evaluating RZ402 for diabetic macular edema. The study status is shown as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RZ402 (RZ402)

Snippet

Sponsor: Rezolute | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED